{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:25:54Z","timestamp":1777605954055,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["NCT00001260"],"award-info":[{"award-number":["NCT00001260"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["900142"],"award-info":[{"award-number":["900142"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.euroneuro.2018.10.007","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:22:03Z","timestamp":1541463723000},"page":"137-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["The effect of body mass index on glucagon-like peptide receptor gene expression in the post mortem brain from individuals with mood and psychotic disorders"],"prefix":"10.1016","volume":"29","author":[{"given":"Rodrigo B.","family":"Mansur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel R.","family":"Fries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6065-9355","authenticated-orcid":false,"given":"Alisson P.","family":"Trevizol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehala","family":"Subramaniapillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Lovshin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangguang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maj","family":"Vinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger C.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Brietzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2018.10.007_bib0001","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1038\/tp.2016.261","article-title":"The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies","volume":"7","author":"Amare","year":"2017","journal-title":"Trans. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2016.09.010","article-title":"Influence of glucagon-like peptide 2 on energy homeostasis","volume":"86","author":"Baldassano","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0003","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jnr.21483","article-title":"Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease","volume":"86","author":"Bertilsson","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0004","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1586\/ern.10.185","article-title":"Insulin dysfunction and allostatic load in bipolar disorder","volume":"11","author":"Brietzke","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/07853890.2012.687835","article-title":"The relationship between bipolar disorder and Type 2 diabetes: more than just co-morbid disorders","volume":"45","author":"Calkin","year":"2013","journal-title":"Ann. Med."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0006","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.psyneuen.2016.04.002","article-title":"Mood and metabolism: anhedonia as a clinical target in type 2 diabetes","volume":"69","author":"Carter","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0007","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1525-1578(10)60455-2","article-title":"Analysis of microarray data using Z score transformation","volume":"5","author":"Cheadle","year":"2003","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0008","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0009","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-016-3874-y","volume":"59","author":"Farr","year":"2016","journal-title":"Diabetologia"},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2018.10.007_bib0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2008.03.025","article-title":"GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid","volume":"587","author":"Gault","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0011","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2010.59","article-title":"Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet","volume":"34","author":"Gault","year":"2010","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0012","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neurobiolaging.2010.02.014","article-title":"Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP\/PS1 mice","volume":"33","author":"Gengler","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0013","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/fcp.12329","article-title":"Exenatide upregulates gene expression of glucagon-like peptide-1 receptor and nerve growth factor in streptozotocin\/nicotinamide-induced diabetic mice","volume":"32","author":"Gumuslu","year":"2018","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0014","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2215-0366(15)00115-7","article-title":"Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses","volume":"2","author":"Henderson","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0015","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.molmet.2015.09.007","article-title":"Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans","volume":"4","author":"Heni","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0016","doi-asserted-by":"crossref","DOI":"10.1111\/acps.12711","article-title":"No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia","author":"Ishoy","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0017","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neures.2006.04.008","article-title":"Glucagon-like peptide-1 inhibits LPS-induced IL-1beta production in cultured rat astrocytes","volume":"55","author":"Iwai","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0018","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neures.2009.01.013","article-title":"The influences of juvenile diabetes on memory and hippocampal plasticity in rats: improving effects of glucagon-like peptide-1","volume":"64","author":"Iwai","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0019","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/1742-2094-9-276","article-title":"GLP-1 secretion by microglial cells and decreased CNS expression in obesity","volume":"9","author":"Kappe","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2013.01.012","article-title":"Exendin (5\u201339), an antagonist of GLP-1 receptor, modulates synaptic transmission via glutamate uptake in the dentate gyrus","volume":"1505","author":"Kobayashi","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0021","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s00125-012-2592-3","article-title":"Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes","volume":"55","author":"Lee","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0022","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3233\/JAD-2010-1314","article-title":"GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease","volume":"19","author":"Li","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0023","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.biopsych.2006.06.019","article-title":"Critical factors in gene expression in postmortem human brain: focus on studies in schizophrenia","volume":"60","author":"Lipska","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0024","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jad.2016.09.056","article-title":"Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: a pilot, open-label study","volume":"207","author":"Mansur","year":"2017","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neubiorev.2014.12.017","article-title":"Is there a \"metabolic-mood syndrome\"? A review of the relationship between obesity and mood disorders","volume":"52","author":"Mansur","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2017.08.433","article-title":"Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders","author":"Mansur","year":"2017","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"Pt A","key":"10.1016\/j.euroneuro.2018.10.007_bib0027","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","article-title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer's disease","volume":"76","author":"McClean","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0028","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease","volume":"31","author":"McClean","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0029","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12325-014-0105-0","article-title":"A vision for drug discovery and development: novel targets and multilateral partnerships","volume":"31","author":"McIntyre","year":"2014","journal-title":"Adv. Ther."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0030","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/mp.2017.51","article-title":"Prefrontal gray matter volume mediates genetic risks for obesity","volume":"22","author":"Opel","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0031","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1124\/jpet.102.037481","article-title":"Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4","volume":"302","author":"Perry","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0032","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","article-title":"Impaired glucose homeostasis in first-episode Schizophrenia: a systematic review and meta-analysis","volume":"74","author":"Pillinger","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0033","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1463-1326.2010.01259.x","article-title":"Four weeks administration of liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance","volume":"12","author":"Porter","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0034","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13073-017-0458-5","article-title":"Post-mortem molecular profiling of three psychiatric disorders","volume":"9","author":"Ramaker","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0035","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1210\/en.2014-1248","article-title":"GLP-1 receptor stimulation of the lateral parabrachial nucleus reduces food intake: neuroanatomical, electrophysiological, and behavioral evidence","volume":"155","author":"Richard","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0036","first-page":"R582","article-title":"Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus","volume":"277","author":"Rinaman","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"7","key":"10.1016\/j.euroneuro.2018.10.007_bib0037","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0038","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/oby.21253","article-title":"Altered intestinal neuroendocrine gene expression in humans with obesity","volume":"23","author":"Ritze","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0039","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cmet.2016.08.020","article-title":"Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes","volume":"24","author":"Segerstolpe","year":"2016","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.euroneuro.2018.10.007_bib0040","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2015-3291","article-title":"Decreased hypothalamic glucagon-like peptide-1 receptor expression in type 2 diabetes patients","volume":"101","author":"Ten Kulve","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0041","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/2042018814559725","article-title":"GLP-1 receptor agonists: a review of head-to-head clinical studies","volume":"6","author":"Trujillo","year":"2015","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0042","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.2337\/db14-0849","article-title":"GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans","volume":"63","author":"van Bloemendaal","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0043","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.14r09635","article-title":"Prevalence and predictors of type 2 diabetes mellitus in people with bipolar disorder: a systematic review and meta-analysis","author":"Vancampfort","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0044","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/da.22387","article-title":"Type 2 diabetes in patients with major depressive disorder: a meta-analysis of prevalence estimates and predictors","volume":"32","author":"Vancampfort","year":"2015","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0045","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.neuroscience.2010.08.028","article-title":"Val8-glucagon-like peptide-1 protects against Abeta1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats","volume":"170","author":"Wang","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2018.04.031","article-title":"Liraglutide attenuates the depressive- and anxiety-like behaviour in the corticosterone induced depression model via improving hippocampal neural plasticity","author":"Weina","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2018.10.007_bib0047","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ijo.2016.222","article-title":"The obese brain as a heritable phenotype: a combined morphometry and twin study","volume":"41","author":"Weise","year":"2017","journal-title":"Int. J. Obes (Lond.)"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18308423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18308423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T11:38:26Z","timestamp":1565264306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X18308423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0924977X18308423"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.10.007","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of body mass index on glucagon-like peptide receptor gene expression in the post mortem brain from individuals with mood and psychotic disorders","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}